dichlororibofuranosylbenzimidazole has been researched along with Cancer of Lung in 3 studies
Dichlororibofuranosylbenzimidazole: An RNA polymerase II transcriptional inhibitor. This compound terminates transcription prematurely by selective inhibition of RNA synthesis. It is used in research to study underlying mechanisms of cellular regulation.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Qu, LY | 1 |
Jiang, YL | 1 |
Tang, XW | 1 |
Shan, B | 1 |
Zhuo, Y | 1 |
Chin, D | 1 |
Morris, CA | 1 |
Morris, GF | 1 |
Lasky, JA | 1 |
Lange-Carter, CA | 1 |
Malkinson, AM | 1 |
3 other studies available for dichlororibofuranosylbenzimidazole and Cancer of Lung
Article | Year |
---|---|
[Effect of DRB/alpha-Amanitin on localization of Nrf2 in A549 cells].
Topics: 20-Hydroxysteroid Dehydrogenases; Alpha-Amanitin; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; | 2010 |
Cyclin-dependent kinase 9 is required for tumor necrosis factor-alpha-stimulated matrix metalloproteinase-9 expression in human lung adenocarcinoma cells.
Topics: Adenocarcinoma; Cell Line, Tumor; Culture Media, Conditioned; Cyclin T; Cyclin-Dependent Kinase 9; C | 2005 |
Differential regulation of the stability of cyclic AMP-dependent protein kinase messenger RNA in normal versus neoplastic mouse lung epithelial cells.
Topics: Animals; Blotting, Northern; Cycloheximide; Dichlororibofuranosylbenzimidazole; Epithelium; Gene Exp | 1991 |